Unique Ingredient Identifier TZX5469Z6I is listed as a ingredient substance
| RN | 7631-90-5 |
| EC | 231-548-0 |
| NCIT | C73837 |
| RXCUI | 1366858 |
| PUBCHEM | 23665763 |
| MF | Na.HO3S |
| INCHI KEY | DWAQJAXMDSEUJJ-UHFFFAOYSA-M |
| SMILES | [Na+].OS([O-])=O |
UNII TZX5469Z6I SODIUM BISULFITE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | 0.2 % |
| AURICULAR (OTIC) | SOLUTION | 0.1 % |
| AURICULAR (OTIC) | SUSPENSION | 0.001 % |
| EPIDURAL | INJECTION | NA |
| IM - IV | INJECTION | 0.66 % |
| IM - IV | POWDER, FOR INJECTION SOLUTION | 5.18 % |
| IM - IV | SOLUTION, INJECTION | NA |
| IM - IV - SC | INJECTION | 0.5 % |
| INHALATION | INHALANT | 0.075 % |
| INHALATION | SOLUTION | 0.3 % |
| INTRA-ARTERIAL | INJECTION | NA |
| INTRA-ARTICULAR | INJECTION | 0.32 % |
| INTRA-ARTICULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRABURSAL | INJECTION | NA |
| INTRACARDIAC | INJECTION | 0.1 % |
| INTRADERMAL | INJECTION, SUSTAINED ACTION | NA |
| INTRADISCAL | POWDER, FOR INJECTION SOLUTION | NA |
| INTRALESIONAL | INJECTION | 0.32 % |
| INTRALESIONAL | INJECTION, SUSTAINED ACTION | NA |
| INTRAMUSCULAR | INJECTION | 0.66 %W/V |
| INTRAMUSCULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRAPERITONEAL | INJECTION | 0.66 % |
| INTRAPERITONEAL | SOLUTION | NA |
| INTRASYNOVIAL | INJECTION | 0.32 % |
| INTRASYNOVIAL | INJECTION, SUSTAINED ACTION | NA |
| INTRAVENOUS | INJECTION | 1.6 % |
| INTRAVENOUS | SOLUTION, INJECTION | 0.05 % |
| IONTOPHORESIS | SOLUTION | 0.055 % |
| IRRIGATION | INJECTION | 0.33 % |
| IV(INFUSION) | INJECTION | 5 % |
| IV(INFUSION) | SOLUTION, INJECTION | 0.024 % |
| NERVE BLOCK | INJECTION | 2.2 % |
| OPHTHALMIC | SOLUTION | 0.1 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.1 % |
| OPHTHALMIC | SUSPENSION | 0.06 % |
| ORAL | CAPSULE | 0.36 MG |
| ORAL | CONCENTRATE | 0.5 MG/1ML |
| ORAL | SOLUTION | 0.1 % |
| ORAL | SUSPENSION | 2 MG/5ML |
| ORAL | SYRUP | NA |
| ORAL | TABLET | 3 mg |
| SOFT TISSUE | INJECTION | 0.1 % |
| SUBCUTANEOUS | INJECTION | 0.15 % |
| SUBLINGUAL | TABLET | 0.5 MG |
| TOPICAL | EMULSION, CREAM | 0.3 %W/W |
| TOPICAL | LOTION | NA |
| TOPICAL | POWDER, FOR SOLUTION | 0.1 %W/V |
| TOPICAL | SOLUTION | 0.055 %W/V |